🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Emmanuel S. Burgos

Melinta Therapeutics (United States)

ORCID: 0000-0003-4555-7673
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 5 papers. Top paper: Boosting NAD+ with a small molecule that activates NAMPT.

N/A
0.764DataRank · unranked
162 citations

Meghan Hopf, Asima Khan, Mauro Dispagna, E. Hampton Sessions, Rebecca Falter +13 more

2 citations

Emmanuel S. Burgos, Varun Gupta, Alyssa D. Casill, Brian Kosmyna, Hongshan Chen +4 more

30 citations

Rajesh K. Harijan, Emmanuel S. Burgos, J.B. Bonanno, Steven C. Almo, David Shechter +1 more

4 citations

Rajesh K. Harijan, Emmanuel S. Burgos, J.B. Bonanno, Steven C. Almo, David Shechter +1 more

3 citations

Hongshan Chen, Emmanuel S. Burgos, Maxim I. Maron, Sitaram Gayatri, Edward Nieves +11 more